Replay of: Preventing Radiation Injury: New Medical Countermeasures for the Battlefield and the Clinic – A Virtual Panel Discussion
August 12, 2025
To access the replay and transcript, please complete the form below:
This virtual panel discussion focused on (i) prophylactic medical countermeasures for the U.S. warfighter; and (ii) and their potential dual use for civilian medical applications. The panel featured five subject matter experts with broad and deep experience across clinical, medical, and military dimensions.
Panelists
Colin G. Chinn, MD, MHS, FACP, RADM MC USN (Ret) is Chief Medical Officer, Humanetics Corporation. Admiral Chinn’s perspectives are drawn from clinical, academic, research, operational, and executive medicine leadership roles across four decades of service in the U.S. Navy, including as the 14th Joint Staff Surgeon where he was the senior medical advisor to the Chairman of the Joint Chiefs of Staff. Dr. Chinn served as Clinical Professor of Medicine and Scholar-in-Residence at the Uniformed Services University in Bethesda, Maryland. He served as a member of the Defense Health Board, an independent advisory board for the Secretary of Defense on military health matters. Dr. Chinn is a Fellow of the American College of Physicians, a member of Delta Omega, the National Public Health Honor Society, and achieved board certification in gastroenterology and internal medicine.
Howard A. Crawford, Captain, USAF, MSC (Ret) is President of Patriotic Solutions LLC. He is a retired U.S. Air Force Medical Service Corps Officer. During his Air Force career, he served as a Medic and then a Medical Service Corps Officer overseeing Medical Readiness, Tricare Benefits, Medical procurement and CBRN (Chemical, Biological, Radiological, and Nuclear) Operations. As a pharmaceutical executive, Howard has extensive experience working with government agencies and brings a wealth of knowledge, expertise, and documented success in branded and generic drugs as well as healthcare policy. He is a Sustaining Member of AMSUS (Association of Military Surgeons of America) and served as Chairman and legislative lead. He also volunteers for USAFA as an Academy Admissions Liaison Officer.
Michael D. Kaytor, PhD is Vice President, Research & Development, Humanetics Corporation. Dr. Kaytor built and leads a world-class team of PhD scientists and manufacturing and regulatory experts on a mission to develop BIO 300 (aka BYOGRAYZ™) as a prophylactic Medical Countermeasure for warfighters, and in its dual-use application to protect against normal tissue damage from ionizing radiation during cancer radiotherapy. In addition, due to the anti-inflammatory and anti-fibrotic properties of BIO 300, Dr. Kaytor is leading efforts to develop the drug for pulmonary inflammatory disease indications. Dr. Kaytor has more than twelve years of experience in this role and has been responsible for winning nearly $40MM in federal and state grants and contracts to fund these research programs.
Charles B. Simone, MD is a radiation oncologist, research professor, and Chief Medical Officer of the New York Proton Center, and he is a Full Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. Dr. Simone is an internationally recognized expert in proton therapy, reirradiation, stereotactic body radiation therapy, and innovative clinical trial strategies in thoracic oncology. He is a National Institutes of Health, National Science Foundation, and Department of Defense funded investigator who has published over 660 peer-reviewed scientific articles and book chapters and given more than 640 scientific lectures to national and international audiences. Dr. Simone is also the national Principal Investigator or Co-Chair of eight NIH-funded cooperative group trials.
Gregory A. Smith, Command Chief Master Sergeant (Ret) is Chief Executive Officer of TIGRE Global Solutions Inc., a firm that focuses on emerging technology, discreet capabilities, and developmental systems that advance National Security. Greg’s experience spans more than three decades of forward operating deployments, operational and training leadership roles, and multiple global special operations assignments across the Department of Defense.